Hypothalamic control of energy and glucose metabolism

Reviews in Endocrine and Metabolic Disorders

Volumn 12, Issue 3, 2011, Pages 219-233

  Sisley, Stephanie ^a   Sandoval, Darleen ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Diabetes; Hypothalamus; Metabolism; Obesity

Indexed keywords

DOPAMINE; FATTY ACID SYNTHASE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; LEPTIN; SEROTONIN;

ARTICLE; BODY WEIGHT; CENTRAL NERVOUS SYSTEM; ENERGY METABOLISM; FOOD INTAKE; GLUCOSE METABOLISM; HUMAN; HYPOTHALAMUS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; WEIGHT GAIN;

DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; GLUCOSE; HOMEOSTASIS; HUMANS; HYPOTHALAMUS; INSULIN; OBESITY;

EID: 80054846723     PISSN: 13899155     EISSN: 15732606     Source Type: Journal    
DOI: 10.1007/s11154-011-9189-x     Document Type: Article

References (183)

1. Sandoval D, Cota D, Seeley RJ. The integrative role of CNS fuel-sensing mechanisms in energy balance and glucose regulation. Annu Rev Physiol. 2008;70:513-35. doi:10.1146/ annurev.physiol.70.120806.095256. (Pubitemid 351738190)
2. Langhans W, Geary N. Overview of the physiological control of eating. Forum Nutr. 2010;63:9-53.
3. Yanovski JA, Yanovski SZ, Sovik KN, Nguyen TT, O'Neil PM, Sebring NG. A prospective study of holiday weight gain. N Engl J Med. 2000;342(12):861-7. doi:10.1056/NEJM200003233421206. (Pubitemid 30165210)
4. Polonsky KS, Given BD, Van Cauter E. Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects. J Clin Invest. 1988;81(2):442-8. doi:10.1172/JCI113339. (Pubitemid 18075238)
5. Schwartz MW, Sipols A, Kahn SE, Lattemann DF, Taborsky Jr GJ, Bergman RN, et al. Kinetics and specificity of insulin uptake from plasma into cerebrospinal fluid. Am J Physiol. 1990;259(3 Pt 1):E378-83. (Pubitemid 20320760)
6. Baskin DG, Woods SC, West DB, van Houten M, Posner BI, Dorsa DM, et al. Immunocytochemical detection of insulin in rat hypothalamus and its possible uptake from cerebrospinal fluid. Endocrinology. 1983;113(5):1818-25. (Pubitemid 13023826)
7. Baskin DG, Schwartz MW, Sipols AJ, DAlessio DA, Goldstein BJ, White MF. Insulin receptor substrate-1 (IRS-1) expression in rat brain. Endocrinology 1994;134(4):1952-5. (Pubitemid 24110760)
8. Obici S, Feng Z, Karkanias G, Baskin DG, Rossetti L. Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats. Nat Neurosci. 2002;5(6):566-72. doi:10.1038/nn861. (Pubitemid 34568999)
9. Chavez M, Kaiyala K, Madden LJ, Schwartz MW, Woods SC. Intraventricular insulin and the level of maintained body weight in rats. Behav Neurosci. 1995;109(3):528-31.
10. Bruning JC, Gautam D, Burks DJ, Gillette J, Schubert M, Orban PC, et al. Role of brain insulin receptor in control ofbody weight and reproduction. Science. 2000;289(5487):2122-5.
11. Air EL, Benoit SC, Blake Smith KA, Clegg DJ, Woods SC. Acute third ventricular administration of insulin decreases food intake in two paradigms. Pharmacol Biochem Behav. 2002;72(1-2):423-9. (Pubitemid 34251354)
12. Woods SC, Lotter EC, Mc Kay LD, Porte Jr D. Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons. Nature. 1979;282(5738):503-5. (Pubitemid 10126541)
13. Figlewicz DP, Sipols AJ, Seeley RJ, Chavez M, Woods SC, Porte Jr D. Intraventricular insulin enhances the meal-suppressive efficacy of intraventricular cholecystokinin octapeptide in the baboon. Behav Neurosci. 1995;109(3):567-9.
14. Clegg DJ, Riedy CA, Smith KA, Benoit SC, Woods SC Differential sensitivity to central leptin and insulin in male and female rats. Diabetes. 2003;52(3):682-7. (Pubitemid 36323575)
15. Clegg DJ, Brown LM, Woods SC, Benoit SC Gonadal hormones determine sensitivity to central leptin and insulin. Diabetes. 2006;55(4):978-87. (Pubitemid 44100172)
16. Niswender KD, Morrison CD, Clegg DJ, Olson R, Baskin DG, Myers Jr MG, et al. Insulin activation of phosphatidylinositol 3-kinase in the hypothalamic arcuate nucleus: a key mediator of insulin-induced anorexia. Diabetes. 2003;52(2):227-31. (Pubitemid 36173172)
17. Plum L, Ma X, Hampel B, Balthasar N, Coppari R, Munzberg H, et al. Enhanced PIP3 signaling in POMC neurons causes KATP channel activation and leads to diet-sensitive obesity J Clin Invest. 2006;116(7):1886-901. doi:10.1172/JCI27123. (Pubitemid 44033313)
18. Schwartz MW, Sipols AJ, Marks JL, Sanacora G, White JD, Scheurink A, et al. Inhibition ofhypothalamic neuropeptide Y gene expressionbyinsulin. Endocrinology. 1992;130(6):3608-16.
19. Clegg DJ, Gotoh K, Kemp C, Wortman MD, Benoit SC, Brown LM et al. Consumption of a high-fat diet induces central insulin resistance independent ofadiposity. Physiol Behav. 2011.
20. Clegg DJ, Benoit SC, Reed JA, Woods SC, Dunn-Meynell A, Levin BE. Reduced anorexic effects of insulin in obesity-prone rats fed a moderate-fat diet. Am J Physiol Regul Integr Comp Physiol. 2005;288(4):R981-6. (Pubitemid 40404173)
21. Schwartz MW, Marks JL, Sipols AJ, Baskin DG, Woods SC, Kahn SE, et al. Central insulin administration reduces neuro-peptide Y m RNA expression in the arcuate nucleus of food-deprived lean (Fa/Fa) but not obese (fa/fa) Zucker rats. Endocrinology 1991;128(5):2645-7.
22. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, et al. Serum immunoreactive-leptin concentra-tions in normal-weight and obese humans. N Engl J Med. 1996;334(5):292-5. (Pubitemid 26033933)
23. Schwartz MW, Seeley RJ, Campfield LA, Burn P, Baskin DG. Identification of targets of leptin action in rat hypothalamus. J Clin Invest. 1996;98(5):1101-6. doi:10.1172/JCI118891. (Pubitemid 26299921)
24. Cox JE, Powley TL. Development of obesity in diabetic mice pair-fed with lean siblings. J Comp Physiol Psychol. 1977;91 (2):347-58. (Pubitemid 8087578)
25. Chan TM, Young KM, Hutson NJ, Brumley FT, Exton JH. Hepatic metabolism of genetically diabetic (db/db) mice. I. Carbohydrate metabolism. Am J Physiol. 1975;229(6):1702-12.
26. Mayer J. Genetic factors in obesity. Bull N YAcad Med. 1960;36 (5):323-43.
27. Morton GJ, Niswender KD, Rhodes CJ, Myers Jr MG, Blevins JE, Baskin DG, et al. Arcuate nucleus-specific leptin receptor gene therapy attenuates the obesity phenotype of Koletsky (fa(k)/ fa(k)) rats. Endocrinology 2003;144(5):2016-24. (Pubitemid 36543342)
28. Seeley RJ, van Dijk G, Campfield LA, Smith FJ, Burn P Nelligan JA, et al. Intraventricular leptin reduces food intake and body weight of lean rats but not obese Zucker rats. Horm Metab Res. 1996;28(12):664-8. doi:10.1055/s-2007- 979874. (Pubitemid 27057912)
29. Al-Barazanji KA, Buckingham RE, Arch JR, Haynes A, Mossakowska DE, Mc Bay DL, et al. Effects of intracerebroven-tricular infusion of leptin in obese Zucker rats. Obes Res. 1997;5 (5):387-94. (Pubitemid 127702691)
30. Schwartz MW, Woods SC, Porte Jr D, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature. 2000;404 (6778):661-71. doi:10.1038/35007534. (Pubitemid 30205071)
31. Buettner C, Pocai A, Muse ED, Etgen AM, Myers Jr MG, Rossetti L. Critical role of STAT3 in leptin's metabolic actions. Cell Metab. 2006;4(1):49-60. (Pubitemid 43942253)
32. Gao Q, Wolfgang MJ, Neschen S, Morino K, Horvath TL, Shulman GI, et al. Disruption of neural signal transducer and activator of transcription 3 causes obesity diabetes, infertility, and thermal dysregulation. Proc Natl Acad Sci USA. 2004;101 (13):4661-6. doi:10.1073/pnas.0303992101. (Pubitemid 38437467)
33. Niswender KD, Morton GJ, Stearns WH, Rhodes CJ, Myers Jr MG, Schwartz MW. Intracellular signalling. Key enzyme in leptin-induced anorexia. Nature. 2001;413(6858):794-5. doi:10.1038/35101657. (Pubitemid 33026839)
34. Morton GJ, Gelling RW, Niswender KD, Morrison CD, Rhodes CJ, Schwartz MW Leptin regulates insulin sensitivity via phosphatidylinositol-3-OH kinase signaling in mediobasal hypo-thalamic neurons. Cell Metab. 2005;2(6):411-20.
35. Cota D, Proulx K, Smith KA, Kozma SC, Thomas G, Woods SC, et al. Hypothalamic m TOR signaling regulates food intake. Science. 2006;312(5775):927-30. (Pubitemid 43727328)
36. Cusin I, Zakrzewska KE, Boss O, Muzzin P, Giacobino JP Ricquier D, et al. Chronic central leptin infusion enhances insulin-stimulated glucose metabolism and favors the expression ofuncouplingproteins. Diabetes. 1998;47(7):1014-9. (Pubitemid 28294541)
37. Widdowson PS, Upton R, Buckingham R, Arch J, Williams G. Inhibition offood response to intracerebroventricular injection of leptin is attenuated in rats with diet-induced obesity Diabetes. 1997;46(11):1782-5. (Pubitemid 27456411)
38. Cota D,Matter EK,Woods SC, Seeley RJ. Therole ofhypothalamic mammalian target of rapamycin complex 1 signaling in diet-induced obesity J Neurosci. 2008;28(28):7202-8.
39. Metlakunta AS, Sahu M, Sahu A. Hypothalamic phosphatidyli-nositol 3-kinase pathway of leptin signaling is impaired during the development of diet-induced obesity in FVB/N mice. Endocrinology 2008;149(3):1121-8. (Pubitemid 351397951)
40. Munzberg H, Flier JS, Bjorbaek C. Region-specific leptin resistance within the hypothalamus of diet-induced obese mice. Endocrinology 2004;145(11):4880-9. doi:10.1210/en.2004-0726. (Pubitemid 39551104)
41. Oomura Y Ono T, Ooyama H, Wayner MJ. Glucose and osmosensitive neurones of the rat hypothalamus. Nature. 1969;222(5190):282-4.
42. Anand BK, Chhina GS, Sharma KN, Dua S, Singh B. Activity of single neurons in the hypothalamic feeding centers: effect of glucose. Am J Physiol. 1964;207:1146-54.
43. Burdakov D, Luckman SM, Verkhratsky A. Glucose-sensing neurons of the hypothalamus. Philos Trans R Soc Lond B Biol Sci. 2005;360(1464):2227-35. (Pubitemid 46682141)
44. Ibrahim N, Bosch MA, Smart JL, Qiu J, Rubinstein M, Ronnekleiv OK, et al. Hypothalamic proopiomelanocortin neurons are glucose responsive and express K(ATP) channels. Endocrinology. 2003;144(4):1331-40. (Pubitemid 36428475)
45. Muroya S, Yada T, Shioda S, Takigawa M. Glucose-sensitive neurons in the rat arcuate nucleus contain neuropeptide Y Neurosci Lett. 1999;264(1-3):113-6. (Pubitemid 29195962)
46. Mountjoy PD, Bailey SJ, Rutter GA. Inhibition by glucose or leptin of hypothalamic neurons expressing neuropeptide Y requires changes in AMP-activated protein kinase activity. Diabetologia. 2007;50(1):168-77. doi:10.1007/s00125- 006-0473-3. (Pubitemid 46035865)
47. Fioramonti X, Contie S, Song Z, Routh VH, Lorsignol A, Penicaud L. Characterization of glucosensing neuron subpopu-lations in the arcuate nucleus: integration in neuropeptide Yand pro-opio melanocortin networks? Diabetes. 2007;56(5):1219-27. (Pubitemid 46715601)
48. Davis JD, Wirtshafter D, Asin KE, Brief D. Sustained intra- cerebroventricular infusion of brain fuels reduces body weight and food intake in rats. Science. 1981;212(4490):81-3. (Pubitemid 11114689)
49. Panksepp J, Rossi 3rd J. D-glucose infusions into the basal ventromedial hypothalamus and feeding. Behav Brain Res. 1981;3(3):381-92. (Pubitemid 11020301)
50. Kurata K, Fujimoto K, Sakata T, Etou H, Fukagawa K. D-glucose suppression of eating after intra-third ventricle infusion in rat Physiol Behav. 1986;37(4):615-20. (Pubitemid 16056628)
51. Levin BE, Routh VH, Kang L, Sanders NM, Dunn-Meynell AA. Neuronal glucosensing: what do we know after 50 years? Diabetes. 2004;53(10):2521-8. (Pubitemid 39299257)
52. Miselis RR, Epstein AN. Feeding induced by intracerebroven-tricular 2-deoxy-D-glucose in the rat Am J Physiol. 1975;229 (5):1438-47.
53. Smith GP, Epstein AN Increased feeding in response to decreased glucose utilization in the rat and monkey. Am J Physiol. 1969;217(4):1083-7.
54. Berthoud HR, Mogenson GJ. Ingestive behavior after intracere-bral and intracerebroventricular infusions of glucose and 2-deoxy-D-glucose. Am J Physiol. 1977;233(3):R127-33.
55. Wan HZ, Hulsey MG, Martin RJ. Intracerebroventricular administration of antisense oligodeoxynucleotide against GLUT2 glucose transporter m RNA reduces food intake, body weight change and glucoprivic feeding response in rats. J Nutr 1998;128(2):287-91. (Pubitemid 28125000)
56. Bady I, Marty N, Dallaporta M, Emery M, Gyger J, Tarussio D, et al. Evidence from glut2-null mice that glucose is a critical physiologicalregulatoroffeeding. Diabetes. 2006;55(4):988-95. (Pubitemid 44100173)
57. Miki T Liss B, Minami K, Shiuchi T, Saraya A, Kashima Y et al. ATP-sensitive K+ channels in the hypothalamus are essential for the maintenance of glucose homeostasis. Nat Neurosci. 2001;4 (5):507-12. doi:10.1038/87455. (Pubitemid 32397188)
58. Parton LE, Ye CP, Coppari R, Enriori PJ, Choi B, Zhang CY et al. Glucose sensing by POMC neurons regulates glucose homeostasis and is impaired in obesity Nature. 2007;449 (7159):228-32. (Pubitemid 47402365)
59. Claret M, Smith MA, Batterham RL, Selman C, Choudhury AI, Fryer LG, et al. AMPK is essential for energy homeostasis regulation and glucose sensing by POMC and Ag RP neurons. J Clin Invest. 2007;117(8):2325-36. doi:10.1172/ JCI31516. (Pubitemid 47219577)
60. Clegg DJ, Wortman MD, Benoit SC, Mc Osker CC, Seeley RJ. Comparison of central and peripheral administration of C75 on food intake, body weight, and conditioned taste aversion. Diabetes. 2002;51(11):3196-201. (Pubitemid 35246965)
61. Wortman MD, Clegg DJ, DAlessio D, Woods SC, Seeley RJ. C75 inhibits food intake by increasing CNS glucose metabolism. Nat Med. 2003;9(5):483-5. doi:10.1038/nm0503-483. (Pubitemid 36597076)
62. Lam TK, Pocai A, Gutierrez-Juarez R, Obici S, Bryan J, Aguilar-Bryan L, et al. Hypothalamic sensing of circulating fatty acids is required for glucose homeostasis. Nat Med. 2005;11(3):320-7. (Pubitemid 40460561)
63. Loftus TM, Jaworsky DE, Frehywot GL, Townsend CA, Ronnett GV, Lane MD, et al. Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. Science. 2000;288(5475):2379-81. (Pubitemid 30448165)
64. Hu Z, Dai Y Prentki M, Chohnan S, Lane MD. A role for hypothalamic malonyl-Co A in the control of food intake. J Biol Chem. 2005;280(48):39681-3. (Pubitemid 41779099)
65. Wang R, Cruciani-Guglielmacci C, Migrenne S, Magnan C, Cotero VE, Routh VH. Effects of oleic acid on distinct populations of neurons in the hypothalamic arcuate nucleus are dependent on extracellular glucose levels. J Neurophysiol. 2006;95(3):1491-8.
66. Le Foll C, Irani BG, Magnan C, Dunn-Meynell AA, Levin BE. Characteristics and mechanisms of hypothalamic neuronal fatty acid sensing. Am J Physiol Regul Integr Comp Physiol. 2009;297(3):R655-64.
67. Andrews ZB, Horvath B, Barnstable CJ, Elsworth J, Yang L, Beal MF, et al. Uncoupling protein-2 is critical for nigral dopamine cell survival in a mouse model of Parkinson's disease. J Neurosci. 2005;25(1):184-91. (Pubitemid 40110779)
68. Obici S, Feng Z, Morgan K, Stein D, Karkanias G, Rossetti L. Central administration of oleic acid inhibits glucose production and food intake. Diabetes. 2002;51(2):271-5. (Pubitemid 34764780)
69. He W, Lam TK, Obici S, Rossetti L. Molecular disruption of hypothalamic nutrient sensing induces obesity Nat Neurosci. 2006;9(2):227-33. (Pubitemid 43164546)
70. Morgan K, Obici S, Rossetti L. Hypothalamic responses to long-chain fatty acids are nutritionally regulated. J Biol Chem. 2004;279(30):31139-48. doi:10.1074/jbc.M400458200. (Pubitemid 39037776)
71. Pocai A, Lam TK, Obici S, Gutierrez-Juarez R, Muse ED, Arduini A, et al. Restoration of hypothalamic lipid sensing normalizes energy and glucose homeostasis in overfed rats. J Clin Invest. 2006;116(4):1081-91. doi:10.1172/JCI26640.
72. Chakravarthy MV, Zhu Y Yin L, Coleman T, Pappan KL, Marshall CA, et al. Inactivation of hypothalamic FAS protects mice from diet-induced obesity and inflammation. J Lipid Res. 2009;50(4):630-40.
73. Benoit SC, Kemp CJ, Elias CF, Abplanalp W, Herman JP Migrenne S, et al. Palmitic acid mediates hypothalamic insulin resistance by altering PKC-theta subcellular localization in rodents. J Clin Invest. 2009;119(9):2577-89.
74. Lu M, Sarruf DA, Talukdar S, Sharma S, Li P, Bandyopadhyay G, et al. Brain PPAR-gamma promotes obesity and is required for the insulin-sensitizing effect of thiazolidinediones. Nat Med. 2011;17(5):618-22.
75. Ryan KK, Li B, Grayson BE, Matter EK, Woods SC, Seeley RJ. A role for central nervous system PPAR-gamma in the regulation ofenergy balance. Nat Med. 2011;17(5):623-6.
76. Strader AD, Woods SC. American Gastroenterological Associa-tion. Gastrointestinal hormones and food intake. Rev Gastro-enterol Mex. 2005;70(4):439-57.
77. Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature. 2000;407(6806):908-13. doi:10.1038/ 35038090.
78. Rocca AS, Brubaker PL. Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion. Endocrinology 1999;140(4):1687-94. (Pubitemid 29149238)
79. Merchenthaler I, Lane M, Shughrue P Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system. J Comp Neurol. 1999;403 (2):261-80. doi:10.1002/(SICI)1096- 9861(19990111) 403:23.0.CO;2-5. (Pubitemid 28566834)
80. Han VK, Hynes MA, Jin C, Towle AC, Lauder JM, Lund PK. Cellular localization of proglucagon/glucagon-like peptide I messenger RNAs in rat brain. J Neurosci Res. 1986;16(1):97-107. doi:10.1002/jnr.490160110. (Pubitemid 16050410)
81. van Dijk G, Thiele TE. Glucagon-like peptide-1 (7-36) amide: a central regulator of satiety and interoceptive stress. Neuro-peptides. 1999;33(5):406-14. doi:10.1054/npep.1999.0053. (Pubitemid 29530133)
82. Thiele TE, Seeley RJ, DAlessio D, Eng J, Bernstein IL, Woods SC, et al. Central infusion of glucagon-like peptide-1-(7-36) amide (GLP-1) receptor antagonist attenuates lithium chloride-induced c-Fos induction in rat brainstem. Brain Res. 1998;801 (1-2):164-70. (Pubitemid 28401660)
83. Yamamoto H, Lee CE, Marcus JN, Williams TD, Overton JM, Lopez ME, et al. Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons. J Clin Invest. 2002;110(1):43-52. doi:10.1172/ JCI15595. (Pubitemid 34743464)
84. Osaka T, Endo M, Yamakawa M, Inoue S. Energy expenditure by intravenous administration of glucagon-like peptide-1 mediated by the lower brainstem and sympathoadrenal system. Peptides. 2005;26(9):1623-31. (Pubitemid 41169757)
85. Turton MD, O'Shea D, Gunn I, Beak SA, Edwards CM, Meeran K, et al. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature. 1996;379(6560):69-72. doi:10.1038/379069a0. (Pubitemid 26008136)
86. Tang-Christensen M, Havel PJ, Jacobs RR, Larsen PJ, Cameron JL. Central administration of leptin inhibits food intake and activates the sympathetic nervous system in rhesus macaques. J Clin Endocrinol Metab. 1999;84(2):711-7. (Pubitemid 29075710)
87. Van Dijk G, Thiele TE, Seeley RJ, Woods SC, Bernstein IL. Glucagon-like peptide-1 and satiety Nature. 1997;385 (6613):214. doi:10.1038/385214a0.
88. Naslund E, Gutniak M, Skogar S, Rossner S, Hellstrom PM. Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese men. Am J Clin Nutr 1998;68(3):525-30. (Pubitemid 28402372)
89. Flint A, Raben A, Rehfeld JF, Holst JJ, Astrup A. The effect of glucagon-like peptide-1 on energy expenditure and substrate metabolism in humans. Int J Obes Relat Metab Disord. 2000;24 (3):288-98. (Pubitemid 30137718)
90. Grill HJ, Carmody JS, Amanda Sadacca L, Williams DL, Kaplan JM. Attenuation of lipopolysaccharide anorexia by antagonism of caudal brain stem but not forebrain GLP-1-R. Am J Physiol Regul Integr Comp Physiol. 2004;287(5):R1190-3. doi:10.1152/ ajpregu.00163.2004. (Pubitemid 39391064)
91. Mc Mahon LR, Wellman PJ. PVN infusion of GLP-1-(7-36) amide suppresses feeding but does not induce aversion or alter locomotion in rats. Am J Physiol. 1998;274(1 Pt 2):R23-9.
92. Sandoval DA, Bagnol D, Woods SC, DAlessio DA, Seeley RJ. Arcuate glucagon-like peptide 1 receptors regulate glucose homeostasis but not food intake. Diabetes. 2008;57(8):2046-54.
93. Schusdziarra V, Zimmermann JP, Schick RR. Importance of orexigenic counter-regulation for multiple targeted feeding inhibition. Obes Res. 2004;12(4):627-32. (Pubitemid 41132505)
94. Furuse M, Matsumoto M, Mori R, Sugahara K, Kano K, Hasegawa S. Influence of fasting and neuropeptide Y on the suppressive food intake induced by intracerebroventricular injection ofglucagon-like peptide-1 in the neonatal chick. Brain Res. 1997;764(1-2):289-92. (Pubitemid 27380673)
95. Tritos NA, Vicent D, Gillette J, Ludwig DS, Flier ES, Maratos-Flier E. Functional interactions between melanin-concentrating hormone, neuropeptide Y and anorectic neuropeptides in the rat hypothalamus. Diabetes. 1998;47:1687-92. (Pubitemid 28476241)
96. Edwards CM, Abbott CR, Sunter D, Kim M, Dakin CL, Murphy KG, et al. Cocaine- and amphetamine-regulated transcript, glucagon-like peptide-1 and corticotrophin releasing factor inhibit feeding via agouti-related protein independent pathways in the rat. Brain Res. 2000;866(1-2):128-34. (Pubitemid 30313015)
97. Donahey JC, van Dijk G, Woods SC, Seeley RJ. Intraventricular GLP-1 reduces short- but not long-term food intake or body weight in lean and obese rats. Brain Res. 1998;779(1-2):75-83. (Pubitemid 28039941)
98. D'Alessio DA, Vahl TP Utilizing the GLP-1 signaling system to treat diabetes: sorting through the pharmacologic approaches. Curr Diab Rep. 2005;5(5):346-52. (Pubitemid 41600776)
99. Knop FK, Vilsboll T, Hojberg PV, Larsen S, Madsbad S, Volund A, et al. Reduced incretin effect in type 2 diabetes: cause or consequence of the diabetic state? Diabetes. 2007;56(8):1951-9. (Pubitemid 47195814)
100. Meeran K, O'Shea D, Edwards CM, Turton MD, Heath MM, Gunn I, et al. Repeated intracerebroventricular administration of glucagon-like peptide-1-(7-36) amide or exendin-(9-39) alters body weight in the rat Endocrinology 1999;140(1):244-50. (Pubitemid 29011165)
101. Scrocchi LA, Brown TJ, Ma Clusky N, Brubaker PL, Auerbach AB, Joyner AL, et al. Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene. Nat Med. 1996;2(11):1254-8. (Pubitemid 26375413)
102. Scrocchi LA, Drucker DJ. Effects ofaging and a high fat diet on body weight and glucose tolerance in glucagon-like peptide-1 receptor-/-mice. Endocrinology 1998;139(7):3127-32. (Pubitemid 28512341)
103. Hansotia T, Maida A, Flock G, Yamada Y, Tsukiyama K, Seino Y et al. Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure. J Clin Invest. 2007;117(1):143-52. doi:10.1172/JCI25483. (Pubitemid 46048461)
104. Knauf C, Cani PD, Kim DH, Iglesias MA, Chabo C, Waget A, et al. Role of central nervous system glucagon-like Peptide-1 receptors in enteric glucose sensing. Diabetes. 2008;57 (10):2603-12.
105. Brown M, Bing C, King P, Pickavance L, Heal D, Wilding J. Sibutramine reduces feeding, body fat and improves insulin resistance in dietary-obese male Wistar rats independently of hypothalamic neuropeptide Y Br J Pharmacol. 2001;132 (8):1898-904. doi:10.1038/sj.bjp.0704030. (Pubitemid 32397982)
106. Luo S, Liang Y, Cincotta AH. Intracerebroventricular adminis-tration ofbromocriptine ameliorates the insulin-resistant/glucose-intolerant state in hamsters. Neuroendocrinology 1999;69 (3):160-6. (Pubitemid 29134491)
107. Cincotta AH, Tozzo E, Scislowski PW Bromocriptine/SKF38393 treatment ameliorates obesity and associated metabolic dysfunc-tions in obese (ob/ob) mice. Life Sci. 1997;61(10):951-6. (Pubitemid 27348663)
108. Oltmans GA. Norepinephrine and dopamine levels in hypotha-lamic nuclei of the genetically obese mouse (ob/ob). Brain Res. 1983;273(2):369-73. (Pubitemid 13039723)
109. Salamone JD, Mahan K, Rogers S. Ventrolateral striatal dopamine depletions impair feeding and food handling in rats. Pharmacol Biochem Behav. 1993;44(3):605-10.
110. Szczypka MS, Rainey MA, Kim DS, Alaynick WA, Marck BT, Matsumoto AM, et al. Feeding behavior in dopamine-deficient mice. Proc Natl Acad Sci USA. 1999;96(21):12138-43. (Pubitemid 29502871)
111. Patterson TA, Brot MD, Zavosh A, Schenk JO, Szot P, Figlewicz DP Food deprivation decreases m RNA and activity of the rat dopaminetransporter. Neuroendocrinology 1998;68(1):11-20. (Pubitemid 28310604)
112. Lieberman JA, Stroup TS, Mc Evoy JP, Swartz MS, Rosenheck RA, Perkins DO, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005;353 (12):1209-23. (Pubitemid 41345943)
113. Ader M, Kim SP, Catalano KJ, Ionut V, Hucking K, Richey JM, et al. Metabolic dysregulation with atypical antipsychotics occurs in the absence of underlying disease: a placebo-controlled study of olanzapine and risperidone in dogs. Diabetes. 2005;54 (3):862-71. (Pubitemid 40322092)
114. Houseknecht KL, Robertson AS, Zavadoski W, Gibbs EM, Johnson DE, Rollema H. Acute effects ofatypical antipsychotics on whole-body insulin resistance in rats: implications for adverse metabolic effects. Neuropsychopharmacology. 2007;32(2):289-97. (Pubitemid 46106936)
115. Chintoh AF, Mann SW, Lam L, Lam C, Cohn TA, Fletcher PJ, et al. Insulin resistance and decreased glucose-stimulated insulin secre-tion after acute olanzapine administration. J Clin Psychopharmacol. 2008;28(5):494-9. doi:10.1097/JCP0b013e318184b4c5.
116. Dasgupta A, Singh OP, Rout JK, Saha T, Mandal S. Insulin resistance and metabolic profile in antipsychotic naive schizo-phrenia patients. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34(7):1202-7.
117. Melkersson KI, Gunes A, Dahl ML. Impact of serotonin receptor 2A gene haplotypes on C-peptide levels in clozapine- and olanzapine-treated patients. Hum Psychopharmacol. 2010;25 (4):347-52. doi:10.1002/hup.1114.
118. Mulder H, Cohen D, Scheffer H, Gispen-de Wied C, Arends J, Wilmink FW, et al. HTR2C gene polymorphisms and the metabolic syndrome in patients with schizophrenia: a replication study. J Clin Psychopharmacol. 2009;29(1):16-20. doi:10.1097/ JCP0b013e3181934462.
119. Mancilla-Diaz JM, Escartin-Perez RE, Lopez-Alonso VE, Floran-Garduno B, Romano-Camacho JB. Role of 5-HT1A and 5-HT1B receptors in the hypophagic effect of 5-HT on the structure of feeding behavior Med Sci Monit 2005;11(3):BR74-9. (Pubitemid 40445975)
120. Leibowitz SF, Alexander JT. Hypothalamic serotonin in control of eating behavior, meal size, and body weight. Biol Psychiatry. 1998;44(9):851-64. (Pubitemid 28520223)
121. Choi S, Blake V, Cole S, Fernstrom JD. Effects of chronic fenfluramine administration on hypothalamic neuropeptide m RNA expression. Brain Res. 2006;1087(1):83-6. (Pubitemid 43783148)
122. Nonogaki K, Strack AM, Dallman MF, Tecott LH. Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene. Nat Med. 1998;4 (10):1152-6. doi:10.1038/2647. (Pubitemid 28468828)
123. Xu Y, Jones JE, Kohno D, Williams KW, Lee CE, Choi MJ, et al. 5-HT2CRs expressed by pro-opiomelanocortin neurons regulate energy homeostasis. Neuron. 2008;60(4):582-9.
124. Yamauchi A, Shizuka F, Yamamoto T, Nikawa T, Kido Y Rokutan K, et al. Amino acids and glucose differentially increased extracellular 5-hydroxyindoleacetic acid in the rat brain. J Nutr Sci Vitaminol (Tokyo). 1995;41(3):325-40.
125. Barzilay J, Freedland E. Inflammation and its association with glucose disorders and cardiovascular disease. Treat Endocrinol. 2003;2(2):85-94. (Pubitemid 37055611)
126. Guijarro A, Laviano A, Meguid MM. Hypothalamic integration of immune function and metabolism. Prog Brain Res. 2006;153:367-405.
127. Jansson JO, Wallenius K, Wernstedt I, Ohlsson C, Dickson SL, Wallenius V. On the site and mechanism of action of the anti-obesity effects ofinterleukin-6. Growth Horm IGF Res. 2003;13 (Suppl A):S28-32. (Pubitemid 37161653)
128. Reid J, Lightbody TD. The insulin equivalence of salicylate. Br Med J. 1959;1(5126):897-900.
129. Yuan M, Konstantopoulos N, Lee J, Hansen L, Li ZW, Karin M, et al. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science. 2001;293(5535):1673-7. doi: 10.1126/science.1061620. (Pubitemid 32807849)
130. Yin MJ, Yamamoto Y Gaynor RB. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature. 1998;396(6706):77-80. doi:10.1038/23948. (Pubitemid 28520452)
131. Hundal RS, Petersen KF, Mayerson AB, Randhawa PS, Inzucchi S, Shoelson SE, et al. Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J Clin Invest 2002;109(10):1321-6. doi:10.1172/JCI14955. (Pubitemid 34546896)
132. Rivest S, Lacroix S, Vallieres L, Nadeau S, Zhang J, Laflamme N. How the blood talks to the brain parenchyma and the paraventricular nucleus of the hypothalamus during systemic inflammatory and infectious stimuli. Proc Soc Exp Biol Med. 2000;223(1):22-38. (Pubitemid 30182654)
133. Zhang X, Zhang G, Zhang H, Karin M, Bai H, Cai D. Hypothalamic IKKbeta/NF-kappa B and ER stress link over-nutrition to energy imbalance and obesity. Cell. 2008;135 (1):61-73.
134. Belgardt BF, Mauer J, Wunderlich FT, Ernst MB, Pal M, Spohn G, et al. Hypothalamic and pituitary c-Jun N-terminal kinase 1 signaling coordinately regulates glucose metabolism. Proc Natl Acad Sci USA. 2010;107(13):6028-33.
135. Cincotta AH, Luo S, Zhang Y, Liang Y, Bina KG, Jetton TL, et al. Chronic infusion of norepinephrine into the VMH of normal rats induces the obese glucose-intolerant state. Am J Physiol Regul Integr Comp Physiol. 2000;278(2):R435-44. (Pubitemid 30129634)
136. Posey KA, Clegg DJ, Printz RL, Byun J, Morton GJ, Vivekanandan-Giri A, et al. Hypothalamic proinflammatory lipid accumulation, inflammation, and insulin resistance in rats fed a high-fat diet. Am J Physiol Endocrinol Metab. 2009;296(5): E1003-12.
137. Unger EK, Piper ML, Olofsson LE, Xu AW Functional role of c-Jun-N-terminal kinase in feeding regulation. Endocrinology. 2010;151(2):671-82.
138. De Backer MW Brans MA, van Rozen AJ, van der Zwaal EM, Luijendijk MC, Garner KG, et al. Suppressor of cytokine signaling 3 knockdown in the mediobasal hypothalamus: counterintuitive effects on energy balance. J Mol Endocrinol. 2010;45(5):341-53.
139. Reed AS, Unger EK, Olofsson LE, Piper ML, Myers Jr MG, Xu AW Functional role of suppressor of cytokine signaling 3 upregulation in hypothalamic leptin resistance and long-term energy homeostasis. Diabetes. 2010;59(4):894-906.
140. Kleinridders A, Schenten D, Konner AC, Belgardt BF, Mauer J, Okamura T, et al. My D88 signaling in the CNS is required for development of fatty acid-induced leptin resistance and diet-induced obesity. Cell Metab. 2009;10(4):249-59.
141. Milanski M, Degasperi G, Coope A, Morari J, Denis R, Cintra DE, et al. Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signal-ing in hypothalamus: implications for the pathogenesis of obesity J Neurosci. 2009;29(2):359-70.
142. Ozcan L, Ergin AS, Lu A, Chung J, Sarkar S, Nie D, et al. Endoplasmic reticulum stress plays a central role in development of leptin resistance. Cell Metab. 2009;9(1):35-51.
143. Lam TK, Gutierrez-Juarez R, Pocai A, Rossetti L. Regulation of blood glucose by hypothalamic pyruvate metabolism. Science. 2005;309(5736):943-7. (Pubitemid 41099933)
144. Pocai A, Lam TK, Gutierrez-Juarez R, Obici S, Schwartz GJ, Bryan J, et al. Hypothalamic K(ATP) channels control hepatic glucose production. Nature. 2005;434(7036):1026-31. (Pubitemid 40586051)
145. Obici S, Feng Z, Arduini A, Conti R, Rossetti L. Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production. Nat Med. 2003;9(6):756-61. doi:10.1038/nm873. (Pubitemid 36749226)
146. Wang PY, Caspi L, Lam CK, Chari M, Li X, Light PE, et al. Upper intestinal lipids trigger a gut-brain-liver axis to regulate glucose production. Nature. 2008;452(7190):1012-6. (Pubitemid 351589616)
147. Inoue H, Ogawa W, Asakawa A, Okamoto Y, Nishizawa A, Matsumoto M, et al. Role of hepatic STAT3 in brain-insulin action on hepatic glucose production. Cell Metab. 2006;3 (4):267-75.
148. Konner AC, Janoschek R, Plum L, Jordan SD, Rother E, Ma X, et al. Insulin action in Ag RP-expressing neurons is required for suppression of hepatic glucose production. Cell Metab. 2007;5 (6):438-49. (Pubitemid 46825497)
149. Ono H, Pocai A, Wang Y, Sakoda H, Asano T, Backer JM, et al. Activation of hypothalamic S6 kinase mediates diet-induced hepatic insulin resistance in rats. J Clin Invest. 2008;118 (8):2959-68. doi:10.1172/JCI34277.
150. Shi ZQ, Nelson A, Whitcomb L, Wang J, Cohen AM. Intra-cerebroventricular administration of leptin markedly enhances insulin sensitivity and systemic glucose utilization in conscious rats. Metabolism. 1998;47(10):1274-80. (Pubitemid 28469257)
151. Liu L, Karkanias GB, Morales JC, Hawkins M, Barzilai N, Wang J, et al. Intracerebroventricular leptin regulates hepatic but not peripheral glucose fluxes. J Biol Chem. 1998;273 (47):31160-7. (Pubitemid 28533128)
152. Lin CY, Higginbotham DA, Judd RL, White BD. Central leptin increases insulin sensitivity in streptozotocin-induced diabetic rats. Am J Physiol Endocrinol Metab. 2002;282(5):E1084-91. doi:10.1152/ajpendo.00489.2001. (Pubitemid 34654723)
153. Park S, Hong SM, Sung SR, Jung HK. Long-term effects of central leptin and resistin on body weight, insulin resistance, and beta-cell function and mass by the modulation of hypothalamic leptin and insulin signaling. Endocrinology. 2008;149(2):445-54. (Pubitemid 351159338)
154. Pocai A, Morgan K, Buettner C, Gutierrez-Juarez R, Obici S, Rossetti L. Central leptin acutely reverses diet-induced hepatic insulinresistance. Diabetes. 2005;54(11):3182-9. (Pubitemid 43334373)
155. Robertson SA, Leinninger GM, Myers Jr MG. Molecular and neural mediators of leptin action. Physiol Behav. 2008;94 (5):637-42. (Pubitemid 351847627)
156. Zhou L, Sutton GM, Rochford JJ, Semple RK, Lam DD, Oksanen LJ, et al. Serotonin 2C receptor agonists improve type 2 diabetes via melanocortin-4 receptor signaling pathways. Cell Metab. 2007;6(5):398-405. (Pubitemid 350012006)
157. Martins PJ, Haas M, Obici S. Central nervous system delivery of the antipsychotic olanzapine induces hepatic insulin resistance. Diabetes. 2010;59(10):2418-25.
158. Hakansson ML, Meister B. Transcription factor STAT3 in leptin target neurons of the rat hypothalamus. Neuroendocrinology 1998;68(6):420-7. (Pubitemid 29000851)
159. Horvath TL, Naftolin F, Leranth C. Beta-endorphin innervation of dopamine neurons in the rat hypothalamus: a light and electron microscopic double immunostaining study. Endocrinology. 1992;131(3):1547-55.
160. Hommel JD, Trinko R, Sears RM, Georgescu D, Liu ZW, Gao XB, et al. Leptin receptor signaling in midbrain dopamine neurons regulates feeding. Neuron. 2006;51(6):801-10. (Pubitemid 44374908)
161. Garfield AS, Heisler LK. Pharmacological targeting of the serotonergic system for the treatment of obesity. J Physiol. 2009;587(Pt 1):49-60.
162. Buettner C, Camacho RC. Hypothalamic control of hepatic glucose production and its potential role in insulin resistance. Endocrinol Metab Clin North Am. 2008;37(4):825-40.
163. Perrin C, Knauf C, Burcelin R. Intracerebroventricular infusion of glucose, insulin, and the adenosine monophosphate-activated kinase activator, 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside, controls muscle glycogen synthesis. Endocrinology. 2004;145(9):4025-33. doi:10.1210/en.2004-0270. (Pubitemid 39120547)
164. Minokoshi Y, Okano Y, Shimazu T. Regulatory mechanism of the ventromedial hypothalamus in enhancing glucose uptake in skeletal muscles. Brain Res. 1994;649(1-2):343-7. (Pubitemid 24197233)
165. Minokoshi Y, Haque MS, Shimazu T. Microinjection of leptin into the ventromedial hypothalamus increases glucose uptake in peripheral tissues in rats. Diabetes. 1999;48(2):287-91. (Pubitemid 29061100)
166. Chen M, Woods SC, Porte Jr D. Effect ofcerebral intraventric-ular insulin on pancreatic insulin secretion in the dog. Diabetes. 1975;24(10):910-4.
167. Sako Y, Grill VE. A 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and B cell oxidation through a process likely coupled to fatty acid oxidation. Endocrinology 1990;127(4):1580-9. (Pubitemid 20315212)
168. Zhou YP, Grill VE. Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J Clin Invest. 1994;93(2):870-6. doi:10.1172/ JCI117042. (Pubitemid 24072831)
169. Gremlich S, Bonny C, Waeber G, Thorens B. Fatty acids decrease IDX-1 expression in rat pancreatic islets and reduce GLUT2, glucokinase, insulin, and somatostatin levels. J Biol Chem. 1997;272(48):30261-9. (Pubitemid 27512230)
170. Park S, Ahn IS, da Kim S. Central infusion of leptin improves insulin resistance and suppresses beta-cell function, but not beta-cell mass, primarily through the sympathetic nervous system in a type 2 diabetic rat model. Life Sci. 2010;86(23-24):854-62.
171. Dobbins RL, Szczepaniak LS, Zhang W, Mc Garry JD. Chemical sympathectomy alters regulation of body weight during pro-longed ICV leptin infusion. Am J Physiol Endocrinol Metab. 2003;284(4):E778-87. doi:10.1152/ajpendo.00128.2002. (Pubitemid 36323872)
172. Moran TH, Kinzig KP Gastrointestinal satiety signals II. Cholecystokinin. Am J Physiol Gastrointest Liver Physiol. 2004;286(2):G183-8. doi:10.1152/ajpgi.00434.2003. (Pubitemid 38134028)
173. Chandra R, Liddle RA. Cholecystokinin. Curr Opin Endocrinol Diabetes Obes. 2007;14(1):63-7. doi:10.1097/MED.0b013 e3280122850.
174. Cummings DE, Overduin J. Gastrointestinal regulation of food intake. J Clin Invest. 2007;117(1):13-23. doi:10.1172/JCI30227. (Pubitemid 46048445)
175. Cheung GW, Kokorovic A, Lam CK, Chari M, Lam TK. Intestinal cholecystokinin controls glucose production through a neuronal network. Cell Metab. 2009;10(2):99-109.
176. Schirra J, Nicolaus M, Roggel R, Katschinski M, Storr M, Woerle HJ, et al. Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motil-ity in humans. Gut. 2006;55(2):243-51. (Pubitemid 43117285)
177. Kreymann B, Williams G, Ghatei MA, Bloom SR. Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet. 1987;2 (8571):1300-4. (Pubitemid 17156636)
178. Mojsov S, Weir GC, Habener JF. Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. J Clin Invest. 1987;79(2):616-9. doi:10.1172/JCI112855. (Pubitemid 17009701)
179. Prigeon RL, Quddusi S, Paty B, DAlessio DA. Suppression of glucose production by GLP-1 independent of islet hormones: a novel extrapancreatic effect. Am J Physiol Endocrinol Metab. 2003;285(4):E701-7. doi:10.1152/ajpendo. 00024.2003. (Pubitemid 37176420)
180. Ayala JE, Bracy DP, James FD, Burmeister MA, Wasserman DH, Drucker DJ. Glucagon-like peptide-1 receptor knockout mice are protected from high-fat diet-induced insulin resistance. Endocrinology. 2010;151(10):4678-87.
181. Knauf C, Cani PD, Perrin C, Iglesias MA, Maury JF, Bernard E, et al. Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage. J Clin Invest. 2005;115(12):3554-63. doi:10.1172/JCI25764. (Pubitemid 43121843)
182. Parlevliet ET, de Leeuw van Weenen JE, Romijn JA, Pijl H. GLP-1 treatment reduces endogenous insulin resistance via activation of central GLP-1 receptors in mice fed a high-fat diet. Am J Physiol Endocrinol Metab. 2010;299(2):E318-24.
183. Yamamoto H, Kishi T, Lee CE, Choi BJ, Fang H, Hollenberg AN, et al. Glucagon-like peptide-1-responsive catecholamine neurons in the area postrema link peripheral glucagon-like peptide-1 with central autonomic control sites. J Neurosci. 2003;23(7):2939-46. (Pubitemid 36418630)